Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance

Critical Care Medicine

Volumn 40, Issue 6, 2012, Pages 1731-1737

  Calfee, Carolyn S ^a,b   Gallagher, Diana ^c   Abbott, Jason ^b   Thompson, B Taylor ^d   Matthay, Michael A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute respiratory distress syndrome; angiopoietin 2; biomarkers; endothelial injury; pulmonary edema; von Willebrand factor

Indexed keywords

ANGIOPOIETIN 2; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; FEMALE; FLUID CONSERVATIVE THERAPY; FLUID LIBERAL THERAPY; FLUID THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL;

ACUTE LUNG INJURY; ADULT; AGED; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; FEMALE; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEPSIS; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 84861513903     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182451c87     Document Type: Article

References (21)

1. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
2. Ochoa CD, Wu S, Stevens T: New developments in lung endothelial heterogeneity: Von Willebrand factor, P-selectin, and the Weibel-Palade body. Semin Thromb Hemost 2010; 36:301-308
3. Romani de Wit T, Rondaij MG, Hordijk PL, et al: Real-time imaging of the dynamics and secretory behavior of Weibel-Palade bodies. Arterioscler Thromb Vasc Biol 2003; 23:755-761
4. Rubin DB, Wiener-Kronish JP, Murray JF, et al: Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
5. Flori HR, Ware LB, Milet M, et alL Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2007; 8:96-101
6. Parikh SM, Mammoto T, Schultz A, et al: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46
7. Roviezzo F, Tsigkos S, Kotanidou A, et al: Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005; 314:738-744
8. Orfanos SE, Mavrommati I, Korovesi I, et al: Pulmonary endothelium in acute lung injury: From basic science to the critically ill. Intensive Care Med 2004; 30:1702-1714
9. Ricciuto DR, Dos Santos CC, Hawkes M, et al: Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39:702-710
10. Gallagher DC, Parikh SM, Balonov K, et al: Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008; 29:656-661
11. Meyer NJ, Li M, Feng R, et al: ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011; 183:1344-1353
12. Bhandari V, Choo-Wing R, Lee CG, et al: Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006; 12:1286-1293
13. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
14. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wheeler AP, Bernard GR, et al: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006; 354:2213-2224
15. Kuebler WM, Ying X, Singh B, et al: Pressure is proinflammatory in lung venular capillaries. J Clin Invest 1999; 104:495-502
16. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
17. Eisner MD, Thompson T, Hudson LD, et al: Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164:231-236
18. Vittinghoff E, Glidden D, Shiboski SC, et al: Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, Springer Science?Business Media, 2005
19. van der Heijden M, Pickkers P, van Nieuw Amerongen GP, et al: Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009; 35:1567-1574
20. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, et al: Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008; 63:903-909
21. Ong T, McClintock DE, Kallet RH, et al: Ratio of angiopoietin-2 to angiopoietin-1 as a predictor of mortality in acute lung injury patients. Crit Care Med 2010; 38: 1845-1851